Key Financial Data
| Key Data | Net Sales |
| Sales by Business | Pharmaceuticals: Net Sales |
| Key P&L and Cash Flow | Balance Sheet Structure |
| Per Share Data | |
Key Data
| (m €) | ||||||
|---|---|---|---|---|---|---|
| 2003 | 2004 | 2005 | 2006 | 2007 | ||
| Net Sales | 487.5 (100%) |
488.3 (100%) |
576.1 (100%) |
576.2 (100%) |
628,4 (100%) | |
| Operating Income | 81.0 (16.6%) |
90.4 (18,5%) |
111.1 (19.3%) |
120.3 (20.9%) |
131,5 (20,9%) | |
| Net Income | 23.7 (4.9%) |
54.0 (11.1%) |
64.5 (11.2%) |
74.0 (12.8%) |
84,9 (13,5%) | |
Net Sales
Sales by Business
Pharmaceuticals: Net Sales
Key P&L and Cash Flow
| (m €) | ||||||
|---|---|---|---|---|---|---|
| 2003 | 2004 | 2005 | 2006 | 2007 | ||
| Net Sales | 487.5 | 488.3 | 576.1 | 576.2 | 628,4 | |
| Gross profit as % of Sales |
287.8 59.0% |
309.0 63.3% |
375.5 65.2% |
384.2 66.7% |
422,1 67,2% | |
| Operating Income (EBIT) as % of Sales |
81.0 16.6% |
90.4 18.5% |
111.1 19.3% |
120.3 20.9% |
131,5 20,9% | |
| Pretax Income | 38.4 | 86.7 | 107.0 | 118.2 | 127,4 | |
| Net Income | 23.7 | 54.0 | 64.5 | 74.0 | 84,9 | |
| CASH FLOW | 80.5 | 76.9 | 89.0 | 97.3 | 113,7 | |
Balance Sheet Structure
Per Share Data
| 2003 | 2004 | 2005 | 2006 | 2007 | |
| Earnings per share (EPS) | 0,1225 | 0,270 | 0,326 | 0,370 | 0,427 |
|---|---|---|---|---|---|
| Cash flow per share | 1,625 | 1,336 | 1,621 | 1,836 | 1,989 |
